Pharmacist-Led Assessment of Drug-Induced Liver Injury in Hospitalized Patients
DILI remains under-recognized and under-reported in hospital settings. This study reinforces the potential role of clinical pharmacists in active surveillance using RUCAM and highlights the need for institutional strategies prioritizing the monitoring of liver function in high-risk patients, particularly on general wards.
Authors
- Matheus William Becker (ORCID: https://orcid.org/0000-0002-0190-3688)
- Carine Raquel Blatt (ORCID: https://orcid.org/0000-0001-5935-1196)
- Ana Helena D. P. S. Ulbrich (ORCID: https://orcid.org/0000-0001-6910-8210)
- Karin Hepp Schwambach (ORCID: https://orcid.org/0000-0003-3271-2566)
- Gabriela Xavier Ortiz (ORCID: https://orcid.org/0000-0002-7895-5742)
- Henrique Dias Pereira dos Santos (ORCID: https://orcid.org/0000-0002-2410-3536)
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- Prefeitura Municipal de Alto Alegre (BR)
- Artificial Intelligence in Medicine (Canada) (CA)
- Hospital Mãe de Deus (BR)
Publication Details
- Journal
- The Canadian Journal of Hospital Pharmacy
- Published
- 2025-11-12
- DOI
- https://doi.org/10.4212/cjhp.3827
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00